Table
1: Characteristics of
IFN or PEG-IFN and RBV-induced tongue and oral mucosa hyperpigmentation
Case |
Age |
Sex |
Skin |
HCV |
Dosage |
Duration** |
Hyperpigmentation |
Symptom |
Outcome |
Ref |
|||||
# |
|
|
Color |
GT* |
IFN/RBV |
of Tx (M) |
Tongue |
Gum |
HP |
BM |
Nail |
Skin |
|
(M) |
|
1 |
47 |
F |
Dark |
5 |
IFN
3MU/d; RBV 1,200 mg/d |
9 |
+ |
- |
- |
- |
+ |
+ |
- |
Disappear
(24) |
[2] |
2 |
47 |
M |
Dark |
2a |
*** |
12 |
+ |
- |
- |
- |
- |
+ |
- |
Improved
after dose reduction |
[2] |
3 |
41 |
F |
Dark |
2a |
PEG-IFN
180 μg/w; RBV 400 mg/d |
? |
+ |
- |
- |
- |
- |
+ |
? |
Improved
(2) |
[3] |
4 |
46 |
M |
Dark |
4c |
PEG-IFN
180 μg/w; RBV 1,200 mg/d |
? |
+ |
- |
- |
- |
- |
- |
? |
Unchanged
(6) |
[3] |
5 |
49 |
F |
Dark |
1b |
Same as
#4 |
? |
+ |
- |
- |
- |
- |
+ |
? |
Improved
(3) |
[3] |
6 |
46 |
M |
Dark |
1 |
Same as
#4 |
? |
+ |
- |
- |
- |
- |
- |
? |
Disappeared
during treatment |
[3] |
7 |
40 |
M |
Dark |
4 |
PEG-IFN
180 μg/w; RBV 1,000 mg/d |
? |
+ |
- |
- |
- |
- |
+ |
? |
Unchanged |
[3] |
8 |
45 |
M |
Dark |
3a |
PEG-IFN
80 mg/w; RBV 800 mg/d |
2 |
+ |
- |
- |
- |
- |
- |
? |
Improved
(6) |
[8] |
9 |
54 |
F |
Dark |
1b |
? |
4 |
+ |
- |
- |
+ |
- |
- |
? |
Unchanged
(6) |
[8] |
10 |
53 |
F |
White |
? |
? |
1.5 |
+ |
- |
+ |
- |
- |
- |
+ |
Tx ongoing |
[5] |
(Tongue
Burning) |
|||||||||||||||
11 |
58 |
M |
Dark |
6 |
Same as
#4 |
2 |
+ |
- |
- |
+ |
- |
+ |
? |
Improved
(5) |
[9] |
12 |
33 |
F |
Dark |
1b |
Same as
#8 |
11 |
+ |
+ |
- |
- |
- |
- |
? |
Gum
disappeared (12) Tongue
persisted |
[10] |
13 |
40 |
F |
White |
4 |
Same as
#7 |
3 |
+ |
- |
- |
+ |
- |
- |
+ |
? |
[11] |
(Tongue
discomfort) |
|||||||||||||||
14 |
66 |
F |
Dark |
? |
Same as
#7 |
8 |
+ |
- |
- |
- |
- |
- |
- |
Reduced
(6) |
[12] |
15 |
54 |
F |
White |
1b |
Same as
#8 |
4 |
+ |
- |
- |
- |
- |
- |
- |
? |
[13] |
16 |
36 |
F |
White |
? |
PEG-IFN
120 μg/w; RBV 800 mg/d |
4 |
+ |
- |
- |
- |
- |
- |
+ |
? |
[14] |
(Tongue
sensitive) |
|||||||||||||||
17 |
54 |
F |
Dark |
? |
PEG-IFN1.5
μg/kg/w; RBV 1,000 mg/d |
2 |
+ |
- |
- |
- |
- |
- |
- |
? |
[15] |
18 |
44 |
F |
Dark |
4 |
PEG-IFN
80 μg/w; RBV 1,000 mg/d |
10.5 |
+ |
- |
- |
- |
- |
- |
+ |
Reduced
(6) |
[16] |
(Tongue
discomfort) |
|||||||||||||||
19 |
47 |
F |
Dark |
4 |
? |
2 |
+ |
- |
- |
- |
- |
- |
- |
? |
[17] |
20 |
43 |
M |
Dark |
1b |
Same as
#4 |
1 |
+ |
- |
- |
- |
- |
- |
+ |
Disappeared
(4) |
[18] |
(Oral
discomfort) |
|||||||||||||||
21-27 |
28-66 |
M, F |
**** |
? |
? |
? |
***** |
[4] |
|||||||
28 |
47 |
M |
White |
? |
? |
11 |
+ |
- |
- |
- |
- |
- |
? |
Disappeared
(3) |
[19] |
29 |
49 |
F |
White |
1 |
PEG-IFN
180 μg/w; RBV 1000 mg/d |
1 |
+ |
- |
- |
+ |
- |
- |
+ |
Tx ongoing |
[20] |
(Tongue
Burning) |
|||||||||||||||
30 |
63 |
F |
White |
? |
? |
6 |
+ |
- |
- |
+ |
- |
- |
? |
Improved
(14) |
[21] |
* Abbreviations
and Acronyms used: BM, buccal mucosa; d, day; F,
female; HCV GT, hepatitis C virus genotype; HP, hard palate; IFN, interferon;
M, male; (M), month; MU, million units; PEG-IFN, polyethylene glycol-conjugated
IFN; RBV, ribavirin; Tx, treatment; w, week; ?,
information not available.
** Duration
of treatment in months when hyperpigmentation was noted.
*** IFN: 10
MU/d x 2w, 5 MU/d x 2w, 3 MU/d x 11m, 3 MU 3x/w x 6m; RBV: 1,200 mg/d x 7m, 800
mg/d x 11m.
**** Skin colour
(Fitzpatrick Scale): 2 Type II, 3 Type III, and 2 Type IV.
***** Seven patients
with oral hyperpigmentation involving tongue, hard palate, and/or buccal mucosa; only one patient had symptom (tongue
discomfort). Of these seven patients, four also had melanonychia.